MACRAE SANDY (PRESIDENT, CEO AND DIRECTOR) received a stock award from SANGAMO THERAPEUTICS, INC
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 2/26/2025ACC: 0001415889-25-005704
DirectorOfficer· PRESIDENT, CEO AND DIRECTOR
Since Feb 2026
+2.11M
Net shares
Net buyer
$17.7K
Total sold
0
Open market trades
0B · 0S
4
Total transactions
2.13M acquired · 18.15K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
−7.49K
Price / share
$1.00
Trade value
$7.49K
% of position
0.4%
2/24/2025
2.10M→2.09M
Common Stock
Direct
Shares
−10.66K
Price / share
$0.96
Trade value
$10.19K
% of position
0.5%
2/25/2025
2.09M→2.08M
Common Stock
Direct
Shares
+375K
Price / share
—
Trade value
—
% of position
18.0%
2/25/2025
2.08M→2.45M
Total
Net shares
+356.85K
Net value
-$17.68K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/24/2025 | F · Tax Withholding | −7.49K | $1.00 | $7.49K | 0.4% | 2.10M | 2.09M |
| Common Stock Direct | 2/25/2025 | F · Tax Withholding | −10.66K | $0.96 | $10.19K | 0.5% | 2.09M | 2.08M |
| Common Stock Direct | 2/25/2025 | A · Award | +375K | — | — | 18.0% | 2.08M | 2.45M |
| Total | +356.85K | -$17.68K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
1.75M shares
Shares
+1.75M
Strike price
0.9561
Held after
1.75M
Exercisable
—
2/25/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock1.75M shares | 2/25/2025 | A · Award | +1.75M | 0.9561 | — | 1.75M |